Citigroup
ESMC

Citigroup’s Escalon Medical Corp ESMC Stock Holding History

Citigroup’s Portfolio ESMC Stock Details ESMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-55
Closed – – 8085
2015
Q2 		$0 Sell
55
-218
-80% -$303 ﹤0.01% 7973
2015
Q1 		$0 Buy
+273
New +$395 ﹤0.01% 7637
2014
Q2 		– Sell
-351
Closed -$1K – 7484
2014
Q1 		$1K Buy
+351
New +$619 ﹤0.01% 6925

Other funds holding ESMC

YU
Yale University New Haven, Connecticut $2.05M AUM 1.81% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Citigroup's ESMC Position: Q3 2015 in Review

Citigroup sold out of Escalon Medical Corp (ESMC) in Q3 2015, closing a stake of 55 shares.

Citigroup first reported a position in ESMC in Q1 2014 and held it in 3 quarters. The position peaked at $1K in Q1 2014. 15 funds tracked by Wall St. Rank hold ESMC as of Q3 2015.

  • Citigroup reported no remaining Escalon Medical Corp position as of Q3 2015 after selling out during the quarter.
  • Citigroup sold 55 Escalon Medical Corp shares in Q3 2015.
  • Citigroup first reported a position in Escalon Medical Corp in Q1 2014 and held it in 3 quarters.
  • Citigroup's Escalon Medical Corp position peaked at $1K in Q1 2014.
  • 15 funds tracked by Wall St. Rank held Escalon Medical Corp as of Q3 2015.

Based on Citigroup's 13F filing for Q3 2015, filed 13 Nov 2015.